344 related articles for article (PubMed ID: 22926302)
41. Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients.
Marshall HR; Shakeri S; Hosseiny M; Sisk A; Sayre J; Lu DS; Pantuck A; Raman S
J Vasc Interv Radiol; 2020 Jan; 31(1):15-24. PubMed ID: 31767409
[TBL] [Abstract][Full Text] [Related]
42. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
43. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
[TBL] [Abstract][Full Text] [Related]
44. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors.
Javadi S; Ahrar JU; Ninan E; Gupta S; Matin SF; Ahrar K
J Vasc Interv Radiol; 2010 May; 21(5):690-5. PubMed ID: 20227295
[TBL] [Abstract][Full Text] [Related]
45. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum.
Arellano RS; Garcia RG; Gervais DA; Mueller PR
AJR Am J Roentgenol; 2009 Dec; 193(6):1686-90. PubMed ID: 19933665
[TBL] [Abstract][Full Text] [Related]
46. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
[TBL] [Abstract][Full Text] [Related]
47. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
48. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
49. Limitation for performing ultrasound-guided radiofrequency ablation of small renal masses.
Park BK; Kim CK; Choi HY; Lee HM; Jeon SS; Seo SI; Han DH
Eur J Radiol; 2010 Aug; 75(2):248-52. PubMed ID: 19394181
[TBL] [Abstract][Full Text] [Related]
50. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors.
Ferakis N; Bouropoulos C; Granitsas T; Mylona S; Poulias I
J Endourol; 2010 Dec; 24(12):1909-13. PubMed ID: 20946062
[TBL] [Abstract][Full Text] [Related]
51. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
[TBL] [Abstract][Full Text] [Related]
53. Image-guided ablation of renal cell carcinoma.
Hinshaw JL; Lee FT
Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):429-47, vi. PubMed ID: 15271364
[TBL] [Abstract][Full Text] [Related]
54. Cryoablation vs. radiofrequency ablation for small renal masses.
Pirasteh A; Snyder L; Boncher N; Passalacqua M; Rosenblum D; Prologo JD
Acad Radiol; 2011 Jan; 18(1):97-100. PubMed ID: 20880723
[TBL] [Abstract][Full Text] [Related]
55. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
56. Hepatic radiofrequency under CT-fluoroscopy guidance.
Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
[TBL] [Abstract][Full Text] [Related]
57. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept.
Ritz JP; Lehmann KS; Reissfelder C; Albrecht T; Frericks B; Zurbuchen U; Buhr HJ
Int J Colorectal Dis; 2006 Jan; 21(1):25-32. PubMed ID: 15875202
[TBL] [Abstract][Full Text] [Related]
58. CT-guided navigation of percutaneous hepatic and renal radiofrequency ablation under high-frequency jet ventilation: feasibility study.
Abderhalden S; Biro P; Hechelhammer L; Pfiffner R; Pfammatter T
J Vasc Interv Radiol; 2011 Sep; 22(9):1275-8. PubMed ID: 21703873
[TBL] [Abstract][Full Text] [Related]
59. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
60. Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: a safe and effective approach.
Hegg RM; Schmit GD; Kurup AN; Weisbrod AJ; Boorjian SA; Atwell TD
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):508-12. PubMed ID: 23934115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
